Arch Biopartners Closes Convertible Note Financing

TORONTO, ONTARIO -- (Marketwired) -- 10/24/17 -- Arch Biopartners Inc., ("Arch" or the "Company") (TSX VENTURE: ARCH)(OTCBB: ACHFF), announced it has closed a non-brokered, unsecured convertible note (the "Note") financing for gross proceeds of CAD $500,000 (the "Offering") on October 23, 2017.The Note matures on October 31, 2020 and will be convertible, at the option of the holder, into common shares in the capital of the Company ("Common Shares") at a price per Common Share of $0.50, in the thirty-day period prior to maturity of the Note.Th [...]


read full post from firmenpresse

(164805 Posts)

Leave a Reply